MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-11-2023
TCR2 Therapeutics P/CF Ratio 2011-2026 | TCRR
Annual P/CF Ratio TCR2 Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.571 | -1.55 | -12.2 | -6.98 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.571 | -12.2 | -5.33 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
AbCellera Biologics
ABCL
|
-7.33 | $ 3.55 | -0.28 % | $ 1.06 B |  Canada |
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | Canada |
 |
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | USA |
 |
AC Immune SA
ACIU
|
-4.64 | $ 3.25 | 3.67 % | $ 229 M |  Schweiz |
 |
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
ADC Therapeutics SA
ADCT
|
-5.23 | $ 4.14 | -1.9 % | $ 105 M | Schweiz |
 |
Aptorum Group Limited
APM
|
-3.44 | $ 0.79 | - | $ 4.31 M | China |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Arcturus Therapeutics Holdings
ARCT
|
-2.92 | $ 6.58 | -0.75 % | $ 180 M |  Israel |
 |
argenx SE
ARGX
|
-22.7 | $ 710.26 | 0.99 % | $ 25 B |  Niderland |
 |
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.43 | -4.99 % | $ 8.25 B |  Australia |
 |
Ascendis Pharma A/S
ASND
|
-17.6 | $ 229.93 | -0.47 % | $ 5 B |  Danmark |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | USA |
 |
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | USA |
 |
Atea Pharmaceuticals
AVIR
|
-3.23 | $ 6.09 | 0.58 % | $ 496 M | USA |
 |
BioCardia
BCDA
|
-0.892 | $ 1.31 | 2.91 % | $ 27.7 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | USA |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | Canada |
 |
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 3.47 | -3.07 % | $ 7.55 B | Israel |
 |
Catalyst Biosciences
CBIO
|
989 | $ 11.19 | -3.41 % | $ 1 B | USA |
 |
Anika Therapeutics
ANIK
|
-209 | $ 14.61 | 1.74 % | $ 214 M | USA |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
AVEO Pharmaceuticals
AVEO
|
-1.71 | - | - | $ 521 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | Israel |
 |
CNS Pharmaceuticals
CNSP
|
-0.0304 | $ 2.36 | -3.55 % | $ 902 K | USA |
 |
Aytu BioScience
AYTU
|
-8.14 | $ 2.62 | -0.75 % | $ 16.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.51 | - | $ 385 M | Britain |
 |
BioNTech SE
BNTX
|
70.7 | $ 93.66 | 3.45 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
-0.166 | - | - | $ 269 M | USA |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | USA |